Molecular Partners (MOLN) SEC Filings & 10K Form

$3.79
-0.09 (-2.32%)
(As of 08:17 AM ET)

Recent Molecular Partners SEC Filings

DateFilerForm TypeView
03/26/2024
8:34 AM
Molecular Partners (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2024
11:33 AM
Molecular Partners (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2023
5:05 AM
Molecular Partners (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2023
3:41 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Molecular Partners (Subject)
Form SC 13G/A
11/02/2023
5:01 AM
Molecular Partners (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2023
7:34 AM
Molecular Partners (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/12/2023
5:05 AM
Molecular Partners (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MOLN) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners